DOI:
10.1055/s-00000068
Seminars in Interventional Radiology
LinksClose Window
References
Glund S, Stangier J, Schmohl M , et al.
Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.
Lancet 2015;
386 (9994) 680-690
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.